Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir
Antiretroviral therapy (ART) for HIV-1 has dramatically improved outcomes for people living with HIV-1 but requires life-long adherence and can be associated with short and long-term toxicity. Numerous pre-clinical and clinical investigations are underway to develop therapies for immune control of H...
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Elsevier
2022-06-01
|
| Ráidu: | Journal of Virus Eradication |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2055664022000115 |